BOULDER, Colo., Jan. 26, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the second quarter of fiscal 2015 and hold a conference call to discuss those results on Tuesday, February 3, 2015. Ron Squarer, Chief Executive Officer and Michael Carruthers, Chief Financial Officer will lead the call.
Date: |
Tuesday, February 3, 2015 |
Time: |
9:00 a.m. Eastern Time |
Toll-Free: |
(844) 464-3927 |
Toll: |
(765) 507-2598 |
Pass Code: |
64812242 |
Webcast, including Replay and Conference Call Slides: http://edge.media-server.com/m/p/s2coayon/lan/en |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently enrolling patients. These programs include two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis). For more information on Array, please go to www.arraybiopharma.com.
CONTACT: |
Tricia Haugeto |
Array BioPharma Inc. |
|
(303) 386-1193 |
|
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
SOURCE Array BioPharma Inc.
Share this article